B2A, a receptor modulator, increases the growth of pluripotent and preosteoblast cells through bone morphogenetic protein receptors

References

• Boergermann JH, Kopf J, Yu PB, Knaus P. 2010. Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells. Int J Biochem Cell Biol. 42:1802–1807.
   PubMed Web of Science ®Google Scholar
• Bragdon B, Moseychuk O, Saldanha S, King D, Julian J, Nohe A. 2011. Bone morphogenetic proteins: a critical review. Cell Signal. 23:609–620.
   PubMed Web of Science ®Google Scholar
• Castano E, Dalmau M, Marti M, Berrocal F, Bartrons R, Gil J. 1997. Inhibition of DNA synthesis by aspirin in Swiss 3T3 fibroblasts. J Pharmacol Exp Ther. 280:366–372.
   PubMed Web of Science ®Google Scholar
• Chambard JC, Lefloch R, Pouyssegur J, Lenormand P. 2007. ERK implication in cell cycle regulation. Biochim Biophys Acta. 1773:1299–1310.
   PubMed Web of Science ®Google Scholar
• Cunningham BW, Atkinson BL, Hu N, Kikkawa J, Jenis L, Bryant J, Zamora PO, McAfee PC. 2009. Ceramic granules enhanced with B2A peptide for lumbar interbody spine fusion: An experimental study using an instrumented model in sheep. J Neurosurg Spine. 10:300–307.
   Google Scholar
• Fehrenbacher JC, Burkey TH, Nicol GD, Vasko MR. 2005. Tumor necrosis factor alpha and interleukin-1beta stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells. Pain. 113:113–122.
   PubMed Web of Science ®Google Scholar
• Gallea S, Lallemand F, Atfi A, Rawadi G, Ramez V, Spinella-Jaegle S, Kawai S, Faucheu C, Huet L, Baron R, Roman-Roman S. 2001. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone. 28:491–498.
   PubMed Web of Science ®Google Scholar
• Guicheux J, Lemonnier J, Ghayor C, Suzuki A, Palmer G, Caverzasio J. 2003. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J Bone Miner Res. 18:2060–2068.
   PubMed Web of Science ®Google Scholar
• Hong CC, Yu PB. 2009. Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev. 20:409–418.
   PubMed Web of Science ®Google Scholar
• Li G, White G, Connolly C, Marsh D. 2002. Cell proliferation and apoptosis during fracture healing. J Bone Miner Res. 17 5: 791–799.
   Google Scholar
• Lin X, Zamora PO, Albright S, Glass JD, Pena LA. 2005. Multidomain synthetic peptide B2A2 synergistically enhances BMP-2 in vitro. J Bone Miner Res. 20:693–703.
   PubMed Web of Science ®Google Scholar
• Lin X, Elliot JJ, Carnes DL, Fox WC, Pena LA, Campion SL, Takahashi K, Atkinson BL, Zamora PO. Augmentation of osseous phenotypes in vivo with a synthetic peptide. J Orthop Res. 2007a; 25:531–539.
   Google Scholar
• Lin X, Takahashi K, Liu Y, Derrien A, Zamora PO. A synthetic, bioactive PDGF mimetic with binding to both alpha-PDGF and beta-PDGF receptors. Growth Factors. 2007b; 25:87–93.
   PubMed Web of Science ®Google Scholar
• Lin X, Guo H, Takahashi K, Liu Y, Zamora PO. B2A as a positive BMP receptor modulator. Growth Factors. 2012a; 30:149–157.
   Web of Science ®Google Scholar
• Lin X, Shanmugasundaram S, Liu Y, Derrien A, Nurminskaya M, Zamora PO. B2A peptide induces chondrogenic differentiation in vitro and enhances cartilage repair in rats. J Orthop Res. 2012b; 30:1221–1228.
   Google Scholar
• Manning BD, Cantley LC. 2007. AKT/PKB signaling: Navigating downstream. Cell. 129:1261–1274.
   PubMed Web of Science ®Google Scholar
• McCanless JD, Cole JA, Slack SM, Bumgardner JD, Zamora PO, Haggard WO. Modeling nucleus pulposus regeneration in vitro: Mesenchymal stem cells, alginate beads, hypoxia, BMP-2, and synthetic peptide B2A. Spine (Phila Pa 1976). 20112275–2285.
   Google Scholar
• Miyazono K, Kamiya Y, Morikawa M. 2010. Bone morphogenetic protein receptors and signal transduction. J Biochem. 147:35–51.
   PubMed Web of Science ®Google Scholar
• Moustakas A, Heldin CH. 2005. Non-Smad TGF-beta signals. J Cell Sci. 118:3573–3584.
   PubMed Web of Science ®Google Scholar
• Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI, Knaus P. 2002. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem. 277:5330–5338.
   PubMed Web of Science ®Google Scholar
• Nohe A, Keating E, Knaus P, Petersen NO. 2004. Signal transduction of bone morphogenetic protein receptors. Cell Signal. 16:291–299.
   PubMed Web of Science ®Google Scholar
• Rawadi G, Vayssiere B, Dunn F, Baron R, Roman-Roman S. 2003. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 18:1842–1853.
   PubMed Web of Science ®Google Scholar
• Smucker JD, Bobst JA, Petersen EB, Nepola JV, Fredericks DC. 2008. B2A peptide on ceramic granules enhance posterolateral spinal fusion in rabbits compared with autograft. Spine (Phila Pa 1976). 33:1324–1329.
   PubMed Web of Science ®Google Scholar
• Thawani JP, Wang AC, Than KD, Lin CY, La Marca F, Park P. 2010. Bone morphogenetic proteins and cancer: Review of the literature. Neurosurgery. 66:233–246 discussion 246.
   PubMed Web of Science ®Google Scholar
• Vaes BL, Dechering KJ, van Someren EP, Hendriks JM, van de Ven CJ, Feijen A, Mummery CL, Reinders MJ, Olijve W, van Zoelen EJ, Steegenga WT. 2005. Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone. 36:803–811.
   PubMedGoogle Scholar
• Zhang YE. 2009. Non-Smad pathways in TGF-beta signaling. Cell Res. 19:128–139.
   PubMed Web of Science ®Google Scholar
• Zhang JL, Huang Y, Qiu LY, Nickel J, Sebald W. 2007. von Willebrand factor type C domain-containing proteins regulate bone morphogenetic protein signaling through different recognition mechanisms. J Biol Chem. 282:20002–20014.
   PubMed Web of Science ®Google Scholar
• Zhang JL, Qiu LY, Kotzsch A, Weidauer S, Patterson L, Hammerschmidt M, Sebald W, Mueller TD. 2008. Crystal structure analysis reveals how the chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev Cell. 14:739–750.
   PubMedGoogle Scholar